Stock Screener: Medical , Medical-Biomed-Genetics

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Biomed-Genetics belongs to the sector Medical. This industry has a Market Cap of 724.66B. The top rated companies for Medical-Biomed-Genetics industry are: Amgen (AMGN) , Celgene (CELG) , Gilead Sciences (GILD).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
Amgen (AMGN)
4.3/5 120.05B 16.08 2.13% 1.14%
Biogen Inc (BIIB)
4.2/5 59.79B 16.96 5.5% 1.84%
Gilead Sciences (GILD)
4.2/5 86.6B 6.75 1.27% -33.76%
PDL BioPharma (PDLI)
4.2/5 357.61M 5.72 10.4% -41.01%
Anika Therapeutics (ANIK)
4.2/5 651M 20.47 -0.77% -5.76%
Cambrex (CBM)
4.1/5 1.91B 23.00 -0.26% 25.94%
Myriad Genetics (MYGN)
4.0/5 1.21B 22.08 2.29% -50.55%
Regeneron Pharma (REGN)
3.9/5 39.45B 48.99 0.37% -8.44%
Celgene (CELG)
3.9/5 95.81B 50.61 2.12% 16.71%
China Biologic Products (CBPO)
3.9/5 3.17B 31.57 3.89% -4.27%
Enzo Biochem (ENZ)
3.7/5 407.37M 13.02 -1.58% 71.99%
Incyte (INCY)
3.7/5 25.35B 230.35 -0.12% 67.12%
Innoviva (INVA)
3.7/5 1.4B 25.14 -6.78% -4.18%
Illumina (ILMN)
3.7/5 26.31B 57.99 1.95% 30.38%
Alexion Pharma (ALXN)
3.6/5 26.91B 68.89 0.05% -21.73%
ANI Pharma (ANIP)
3.6/5 588.89M 148.31 2.63% 8.78%
BioTechne Corporation (TECH)
3.5/5 3.85B 49.70 2.43% 11.4%
Emergent Biosolutions (EBS)
3.5/5 1.19B 31.41 3.83% -25.86%
AMAG Pharma (AMAG)
3.4/5 810.59M - 5.7% -14.81%
Repligen (RGEN)
3.4/5 1.2B 101.85 -3.51% 28.26%
Qiagen (QGEN)
3.4/5 6.61B 87.12 3.78% 20.61%
VIVUS (VVUS)
3.3/5 106.64M 4.73 4% -40.57%
MiMedx (MDXG)
3.3/5 1.27B 104.82 0.17% 49.16%
Integra LifeSciences (IART)
3.3/5 3.23B 47.54 5.14% 33.13%
Applied Genetic Technologies (AGTC) 3.2/5 103.08M 10.26 -8.59% -65.2%
Cytokinetics (CYTK)
3.1/5 672.4M 53.17 21.06% 96.91%
Osiris Therapeutics (OSIR) 3.1/5 164M 78.00 0 -21.35
Heska (HSKA)
3.0/5 759.96M 75.23 4.54% 281.9%
Ligand Pharma (LGND)
3.0/5 2.2B - 3.66% -13.61%
Horizon Pharma (HZNP)
3.0/5 2.47B - -0.3% -3.53%
Vertex Pharma (VRTX)
2.8/5 29.3B - 2.3% 39.37%
NeoGenomics (NEO)
2.6/5 663.69M - 1.79% 14.08%
Retrophin (RTRX)
2.6/5 717.99M - 5.44% 32.17%
Exelixis (EXEL)
2.5/5 6.23B - 4.94% 371.79%
Genomic Health (GHDX)
2.5/5 1.07B - 3.15% 16.7%
Acorda Therapeutics (ACOR)
2.4/5 748.13M - 3.13% -43.18%
Vanda Pharmaceuticals (VNDA)
2.4/5 648.22M - 6.05% 60.73%
Sinovac Biotech (SVA)
2.4/5 320.14M - 1.08% -11.48%
Seattle Genetics (SGEN)
2.4/5 9.35B - 0.35% 70.93%
Momenta Pharma (MNTA)
2.4/5 959.24M - 5.32% 48.76%
Alkermes (ALKS)
2.4/5 8.69B - 0.97% 35.42%
Galapagos (GLPG)
2.3/5 4.33B 69.78 -4.06% 89.85%
BioMarin Pharma (BMRN)
2.3/5 16.17B - 4.46% 6.18%
EXACT Sciences (EXAS)
2.3/5 2.71B - 1.26% 240.96%
Kamada (KMDA)
2.2/5 261.51M - 4.35% 83.21%
Nymox Pharmaceutical (NYMX) 2.2/5 217.42M - 5.73% 113.33%
Organovo (ONVO)
2.2/5 285.04M - 6.11% -1.07%
Arna Pharma (ARNA)
2.1/5 418.51M - 9.45% -21.47%
Cellectis (CLLS)
2.1/5 823.54M - 6.51% -15.43%
Idera Pharma (IDRA)
2.1/5 335.46M - 8.22% 36.03%
Array BioPharma (ARRY)
2.1/5 1.41B - 9.44% 176.18%
Regenxbio (RGNX)
2.1/5 650.05M - 0.48% 85.28%
Halozyme Therapeutics (HALO)
2.1/5 1.74B - 8.89% 24.42%
Spark Therapeutics (ONCE)
2.0/5 1.71B - 7.5% 51.42%
Keryx Biopharma (KERX)
2.0/5 627.76M - 2.97% 16.6%
Geron (GERN)
2.0/5 381.98M - 5.81% -18.01%
Amarin (AMRN)
2.0/5 862.43M - -0.95% 69.73%
Compugen (CGEN)
2.0/5 204.53M - 1.27% -41.86%
Curis (CRIS)
1.9/5 365.15M - -1.14% 24.88%
CytomX Therapeutics (CTMX)
1.9/5 608.86M - 9.17% 29.95%
Five Prime Therapeutics (FPRX)
1.9/5 979.8M - 6.6% -27.63%
Intellia Therapeutics (NTLA)
1.8/5 507.96M - 0.85% -35.25%
Acceleron Pharma (XLRN)
1.8/5 1.12B - 7.42% -2.51%
Evogene (EVGN) 1.8/5 129.95M - -1.2% -31.82%
Arbutus Biopharma (ABUS) 1.8/5 181.58M - 1.52% -36.43%
Cellular Biomedicine (CBMG) 1.8/5 154.95M - 0.93% -40.2%
Merrimack Pharma (MACK)
1.8/5 413.91M - 1.9% -56.13%
Acadia Pharma (ACAD)
1.8/5 4.09B - 7.3% 6.41%
Blueprint Medicines (BPMC)
1.8/5 1.77B - -0.77% 168.05%
Inovio Pharma (INO)
1.8/5 485.34M - 11.31% -35.15%
Alnylam Pharma (ALNY)
1.7/5 4.33B - 3.61% -27.03%
Juno Therapeutics (JUNO)
1.7/5 2.63B - 1.38% -42%
MyoKardia (MYOK)
1.7/5 406.85M - 10.88% 7.72%
Abeona Therapeutics (ABEO)
1.7/5 211.34M - 7.92% 99.63%
Celldex Therapeutics (CLDX)
1.7/5 402.84M - 1.23% -16.67%
Aduro BioTech (ADRO)
1.7/5 650.16M - 3.23% -34.96%
Stemline Therapeutics (STML)
1.7/5 219.59M - 4.6% 70.73%
Kite Pharma (KITE)
1.7/5 4.51B - 1.28% 70.27%
Intercept Pharma (ICPT)
1.7/5 2.76B - 8.66% -22.6%
Agenus (AGEN)
1.7/5 353.98M - 9.14% -10.84%
Uniquire (QURE)
1.7/5 125.6M - -9.17% -63.88%
The Medicines Company (MDCO)
1.7/5 3.67B - -7.15% 37.64%
Peregrine Pharma (PPHM)
1.7/5 173.8M - 5.54% 49.24%
Adaptimmune Therapeutics (ADAP)
1.7/5 382.24M - 1.29% -42.01%
Dynavax Technologies (DVAX)
1.7/5 261.34M - 2.65% -72.35%
Adverum (ADVM) 1.7/5 109.36M - 1.92% -56.84%
ZIOPHARM Oncology (ZIOP)
1.6/5 905.46M - 0.14% -12.47%
NewLink Genetics (NLNK)
1.6/5 543.18M - -2.47% 10.75%
Editas (EDIT)
1.6/5 790.38M - 2.49% -46.68%
Achillion Pharma (ACHN)
1.6/5 438.88M - -1.69% -60.81%
bluebird bio (BLUE)
1.6/5 3.51B - 4.53% 91.8%
Mesoblast (MESO)
1.6/5 991.13M - 6.22% 32.99%
Lexicon Pharma (LXRX)
1.5/5 1.58B - 3.48% 9.11%
Proteostasis (PTI)
1.5/5 137.13M - -4.03% -35.36%
Sangamo BioSciences (SGMO)
1.5/5 304.76M - 13.1% -28.36%
Prothena (PRTA)
1.5/5 2.05B - 4.65% 23.07%
Cara Therapeutics (CARA)
1.5/5 527.32M - -5.04% 158.52%
Immunomedics (IMMU)
1.5/5 539.42M - -6.21% 63.36%
Novavax (NVAX)
1.5/5 221.28M - 1.57% -84.73%
Coherus Biosciences (CHRS)
1.5/5 977.04M - 8.04% -1.52%
Merus (MRUS)
1.5/5 324.15M - 6.6% 112.35%
Ascendis Pharma (ASND)
1.5/5 900.33M - 0.72% 59.41%
Epizyme (EPZM)
1.4/5 867.91M - 17.11% 58.2%
Wave Life Sciences (WVE)
1.4/5 476.75M - -1.15% 54.51%
NantKwest (NK)
1.4/5 264.17M - 3.64% -63.96%
Amicus Therapeutics (FOLD)
1.4/5 1.06B - 6.13% -4.39%
Vtv Therapeutics (VTVT)
1.4/5 182.47M - -1.6% -13.3%
MediciNova (MNOV)
1.4/5 187.49M - -2.79% -19.86%
Revance (RVNC)
1.4/5 629.55M - 10.32% 14.02%
Fate Therapeutics (FATE)
1.3/5 190.38M - 4.9% 142.78%
MIRAGEN THERAP (MGEN)
1.3/5 250.67M - 14.75% 52%
Beigene (BGNE)
1.3/5 1.19B - 6.38% 36.99%
Selecta Biosciences (SELB)
1.3/5 248M - -8.66% -7.36%
Alder BioPharma (ALDR)
1.3/5 1.05B - 7.09% -21.39%
Syndax Pharma (SNDX)
1.2/5 187.27M - -12.54% -36.38%
Reata Pharma (RETA)
1.2/5 447.1M - 2.69% 63.43%
Advaxis (ADXS)
1.2/5 333.24M - 3.1% -4.37%
Intra-Cellular Therapies (ITCI)
1.2/5 540.89M - -7.84% -65.74%
OncoMed Pharma (OMED)
1.2/5 141.84M - 4.27% -67.5%
Insmed (INSM)
1.2/5 1.15B - 5.31% 48.72%
Paratek Pharma (PRTK)
1.2/5 580.6M - 1.87% 46.66%
Trevena (TRVN)
1.1/5 188.53M - 2.45% -58.61%
Sarepta Therapeutics (SRPT)
1.0/5 1.86B - 12.5% 224.95%
Asterias Biotherapeutics (AST) - 166.44M - 20.97% -11.56%
IR Biosciences (IRBS) - 0M - 0 -100
Avax Technologies (AVXT) - 1.65M - -33.33% -84.62%
Basilea Pharma (BPMUF) - 976.72M - 0 -0.9
Palatin Technologies (PTN) - 53.83M - 13.57% -22.5%
GeoVax Labs (GOVX) - 3.13M - -11.86% -25.71%
Unigene Laboratories (UGNEQ) - 0.08M - 0 0
Taxus Cardium Pharma (CRXM) - 2.85M - -4.76% 5.26%
Marina Biotech (MRNA) - 30.13M - -12.86% 90.63%
GeneLink (GNLKQ) - 0.19M - 0 0
Nanobac Pharma (NNBP) - 0.15M - 0 0
Introgen Therapeutics (INGNQ) - 0M - N/A N/A
US Stem Cell (USRM) - 24.92M - 4% 30%
Affymax (AFFY) - 1.91M - -1.92% -43.33%
Oncolytics Biotech (ONCYF) - 84.88M - 1.59% 46.86%
Protalix Biotherapeutics (PLX) - 129.1M - -3.85% 14.94%
Rexahn Pharma (RNN) - 98.54M - 6.43% 41.9%
VIA Pharma (VIAP) - 0.15M - 60% 166.67%
CSL Ltd (CMXHY) - 30.75B - N/A N/A
Polymedix (PYMXQ) - 0M - N/A N/A
Dendreon (DNDNQ) - 5.4M - N/A N/A
Amarillo (AMAR) - 6.48M - 17.39% 22.73%
Ultragenyx Pharma (RARE) - 2.56B - 6.78% -8.27%
Myrexis (MYRX) - 2.41M - 29.63 0
Interleukin Genetics (ILIU) - 19.37M - -6.32% -40.67%
Insite Vision (INSV) - 45.85M - N/A N/A
Synthetic Biologics (SYN) - 59.06M - 3.73% -78.41%
ARYx Therapeutics (ARYX) - 0.11M - 0 -25
Immune Therapeutics (IMUN) - 18.88M - 32.08% -58.58%
Bionovo (BNVIQ) - 0.02M - N/A N/A
Panacos Pharma (PANC) - 0.01M - -100 0
Protein Polymer (PPTIQ) - 0.06M - 0 0
Wowi (WOWU) - 9.17B - -3.08% 293.75%
Gliatech (GLIAQ) - 0M - N/A N/A
Cellcyte Genetics (CCYG) - 0.15M - 0 -33.33
Viralytics (VRACY) - 205.05M - -4.12% 38.53%
Cormedix (CRMD) - 45.2M - -6.72% -75.33%
Vital Therapies (VTL) - 149.26M - 7.14% -58.88%
Nicox (NICXF) - 255.66M - 0 25.12
Pfenex (PFNX) - 113M 21.39 9.33% -42.32%
Atara Bio (ATRA) - 463.99M - -4.88% -7.73%
ImmunoCellular Therapeutics (IMUC) - 8.61M - -3.08% -77.3%
International Stem Cell Corp (ISCO) - 6.52M - -4.12% -59.25%
Addex Therapeutics (ADDXF) - 31.62M - 0 -17.54
Theratechnologies (THERF) - 337.43M - 8.13% 195.65%
Biocoral (BCRA) - 1.23M - N/A N/A
BioTime (BTX) - 354.73M 10.09 7.86% 13.58%
Pathfinder Cell (PFND) - 3.14M - 150% 150%
Provectus Biopharma (PVCT) - 16.33M - 12.5% -88.89%
Regenicin (RGIN) - 19.58M - 2.4% 433.33%
Genitope (GTOPQ) - 0.06M - 0 -33.33
ZYTO Corp (KAEN) - 1.22M - -30% 29.63%
Mast Therapeutics (MSTX) - 35.18M - 3.85% -57.01%
Deltagen (DGEN) - 0M - 0 0
Helix Biomedix (HXBM) - 7.84M - 0 0.43
Savient Pharma (SVNTQ) - 0.59M - N/A N/A
USA Equities Corp (USAQ) - 0.02M - 0 -96.67
Nutra Pharma (NPHC) - 1.45M 0.71 0 -66.67
Accentia BioPharma (ABPI) - 0.01M - N/A N/A
Arbutus Biopharma (ABUS) - 181.58M - 1.52% -36.43%
Bellus Health (BLUSF) - 13.46M - -2.9% -85.22%
Quick-Med Technologies (QMDT) - 2.05M - -1.79% 175%
Redpoint Bio (RPBC) - 0.07M - 0 0
Health Discovery (HDVY) - 1.9M - 0 -82.05
Respirerx Pharma (RSPI) - 6.72M - 0.98% -49.42%
NeurogesX (NGSX) - 0.17M - N/A N/A
HedgePath Pharma (HPPI) - 108.33M - -12.29% 119.29%
iBio (IBIO) - 35.64M - 0.25% -37.34%
YBCC INC (YBAO) - 4.32M - 0 -23.7
Synvista Therapeutics (SYNI) - 0M 0.00 0 0
PROTAGENIC THER (PTIX) - 22.58M - 0 -90.51
Biocurex (BOCX) - 0M - N/A N/A
Puma Biotech (PBYI) - 1.38B - 2.95% 18.88%
Response Genetics (RGDXQ) - 0.02M - 0 0
Genmab (GNMSF) - 11.41B 108.62 4.9% 32.57%
Cel-Sci Corporation (CVM) - 21M - 22.22% -80.5%